AGP Executive Report
Last update: an hour agoEbola vaccine push (Canada): Health Canada has authorized Moderna to start a Phase 1 mRNA vaccine trial targeting the Bundibugyo Ebola strain driving the Congo outbreak, with 80 healthy adult volunteers planned across three Canadian sites (Truro, Halifax, Toronto) and no virus exposure for participants. Rare disease access (Saskatchewan): Saskatchewan coverage now includes Alyftrek for cystic fibrosis patients ages 6+ who have one of 266 eligible genetic mutations, following Health Canada guidance and pan-Canadian pricing negotiations. Consumer health leadership (Haleon): Haleon Canada appointed Daniela Cavinatto as general manager, tasking her with growing brands like Advil, Sensodyne and Centrum. Youth mental health (Canada): A call for a “full scale-up” of integrated youth mental health services argues Canada’s 12–25 support hubs still leave major gaps as youth reporting poor mental health rises. Wildfire health (B.C.): Environment Canada issued an air quality warning for the eastern Fraser Valley, urging people to limit outdoor exertion and protect vulnerable groups from smoke exposure. Digital safety (Roblox): Roblox says it’s continuing to push for age-appropriate digital safety standards, pointing to age checks and age-based accounts amid ongoing legal pressure.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
